Phillip Coffin, MD, MIA
PROJECT RESIN: This study is examining the reliability, validity, and acceptability of a novel visual scale for estimating daily methamphetamine use among people who use methamphetamine.
Methamphetamine is a widely used psychostimulant associated with substantial cardiovascular and neuropsychiatric morbidity. The toxic effects of methamphetamine are dose-dependent, but clinical trials of interventions for methamphetamine use disorder often rely on urine drug screening as a primary outcome. Urine drug screening provides qualitative results and can remain positive for 5-7 days after using methamphetamine, thus limiting its use in trials that seek to measure use reduction and not only abstinence as a treatment outcome. Existing methods of measuring the frequency and amount of me…
Inclusion Criteria: * Age 20-40 inclusive * English speaking * Self-reports using methamphetamine at least once in the past 7 days (attempts will be made to enroll participants with varied frequencies of methamphetamine use) * At least 1cm of untreated occipital scalp hair * Hair is brown or black * Willing to provide a hair sample Exclusion Criteria: * Participant, in the opinion of the investigators, would be unable to complete study procedures
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.